tiprankstipranks
Trending News
More News >
Legend Biotech Corporation (LEGN)
NASDAQ:LEGN
US Market

Legend Biotech (LEGN) Financial Statements

Compare
648 Followers

Legend Biotech Financial Overview

Legend Biotech's market cap is currently $3.43B. The company's EPS TTM is $-0.08; its P/E ratio is -6.73; Legend Biotech is scheduled to report earnings on March 10, 2026, and the estimated EPS forecast is $0.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 1.03B$ 627.24M$ 285.14M$ 117.00M$ 68.83M
Gross Profit$ 622.44M$ 392.66M$ 140.93M$ 51.64M$ 68.83M
Operating Income$ -136.86M$ -303.24M$ -439.49M$ -455.62M$ -392.29M
EBITDA$ -107.78M$ -113.16M$ -477.87M$ -416.54M$ -392.38M
Net Income$ -297.58M$ -177.03M$ -518.25M$ -446.35M$ -403.58M
Balance Sheet
Cash & Short-Term Investments$ 948.60M$ 1.12B$ 1.31B$ 1.03B$ 882.39M
Total Assets$ 1.73B$ 1.67B$ 1.85B$ 1.33B$ 1.12B
Total Debt$ 413.70M$ 350.60M$ 328.67M$ 284.53M$ 122.97M
Net Debt$ -488.20M$ 63.85M$ -949.04M$ -501.50M$ -565.97M
Total Liabilities$ 723.60M$ 629.61M$ 597.24M$ 586.65M$ 353.52M
Stockholders' Equity$ 1.00B$ 1.04B$ 1.25B$ 744.31M$ 765.94M
Cash Flow
Free Cash Flow$ -168.04M$ -158.14M$ -416.00M$ -223.56M$ -243.87M
Operating Cash Flow$ -100.47M$ -144.03M$ -393.28M$ -201.28M$ -198.47M
Investing Cash Flow$ 711.48M$ -850.54M$ 92.79M$ -77.09M$ -194.98M
Financing Cash Flow$ -300.79K$ 5.70M$ 791.49M$ 377.98M$ 626.66M
Currency in USD

Legend Biotech Earnings and Revenue History

Legend Biotech Debt to Assets

Legend Biotech Cash Flow

Legend Biotech Forecast EPS vs Actual EPS